Health (Notification of Stimulant Induced Psychosis) Regulations 2010 (WA)
Western Australia
Health (Miscellaneous Provisions) Act 1911
Western Australia
Western Australia
Health (Miscellaneous Provisions) Act 1911Health (Miscellaneous Provisions) Act 1911
These regulations are the
These regulations come into operation as follows —
(a) regulations 1 and 2 — on the day on which these regulations are published in the
Gazette ;(b) the rest of the regulations — on the day that is 3 months after that day.
In these regulations —
(a) information contained in a notification given to the CEO under regulation 5;
(b) information provided to the CEO under regulation 6;
(a) amphetamine; or
(b) cocaine; or
(c) dexamphetamine; or
(d) methylphenidate; or
(e) methylamphetamine; or
(f) any of the salts of a substance referred to in paragraphs (a) to (e); or
(g) any preparation or admixture containing a substance referred to in paragraphs (a) to (f);
Stimulant induced psychosis is prescribed as a condition of health to which Part IXA of the Act applies.
(1) A psychiatrist who makes a diagnosis of stimulant induced psychosis in respect of a patient must notify the CEO within 72 hours of making the diagnosis.
Penalty: a fine of not more than $1 000 and not less than —
(a) for a first offence, $100;
(b) for a second offence, $200;
(c) for a third or subsequent offence, $500.
(2) The notice must be in an approved form and must include the following information —
(a) the full name and address of the patient;
(b) the sex and date of birth of the patient;
(c) full details of the diagnosis including details of the stimulant involved (if known);
(d) the full name, address and telephone number of the psychiatrist giving the notification.
6. CEO may require information (1) If the CEO —
(a) is notified of a diagnosis of stimulant induced psychosis under regulation 5; and
(b) believes, on reasonable grounds, that a person has information that the CEO considers would assist in achieving the objects of Part IXA of the Act with respect to the diagnosis,
the CEO may, in writing, request the person to provide the information.
(2) A person who receives a request under subregulation (1) must comply with the request within 72 hours after receiving it.
Penalty: a fine of not more than $1 000 and not less than —
(a) for a first offence, $100;
(b) for a second offence, $200;
(c) for a third or subsequent offence, $500.
(3) It is a defence to a prosecution for an offence under subregulation (2) if the person charged proves that the person did not have at the relevant time the information requested.
(1) The CEO is to keep a register to be known as the Stimulant Induced Psychosis Register.
(2) The register is to contain all notified information in respect of each patient who has been prescribed or supplied a stimulant under the
Medicines and Poisons Regulations 2016 regulation 126 in the previous 6 months.(3) The register is to be kept in the manner and form determined by the CEO.
A person who, in the course of the person’s duty, has access to any notified information from which the identity of the person to whom the information relates is apparent or can reasonably be ascertained must not disclose that information unless the disclosure —
(a) is made with the written consent of the person to whom the information relates; or
(b) is to a medical practitioner or authorised health professional who —
(i) is authorised under the
Medicines and Poisons Regulations 2016 regulation 126 to prescribe or supply a stimulant for the treatment of the person to whom the information relates; and(ii) has prescribed or supplied the stimulant to the person.
Penalty: a fine of not more than $1 000 and not less than —
(a) for a first offence, $100;
(b) for a second offence, $200;
(c) for a third or subsequent offence, $500.
This is a compilation of the
7 Jan 2011 p. 46‑9 | r. 1 and 2: 7 Jan 2011 (see r. 2(a)); Regulations other than r. 1 and 2: 7 Apr 2011 (see r. 2(b)) | |
29 Dec 2015 p. 5172 | r. 1 and 2: 29 Dec 2015 (see r. 2(a)); Regulations other than r. 1 and 2: 30 Dec 2015 (see r. 2(b)) | |
17 Jan 2017 p. 409‑11 | 30 Jan 2017 (see r. 2(b) and | |
SL 2024/265 11 Dec 2024 | 12 Dec 2024 (see r. 2(c)) | |
approved............................................................................................................................ 3
notified information......................................................................................................... 3
psychiatrist........................................................................................................................ 3
register............................................................................................................................... 3
stimulant............................................................................................................................ 3
stimulant induced psychosis.......................................................................................... 3
|
0
0
0